Komboglyze 2.5mg-850mg Tablets | License Info

Company:
AstraZeneca Pharmaceuticals (Ireland) DAC
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may be renewed (B)
Active Ingredient(s):
Metformin Hydrochloride Saxagliptin Hydrochloride
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/11/731/001

2.5/850 milligram(s)

A10BD10

Film-coated tablet

EU/1/11/731/013

2.5/850 milligram(s)

A10BD10

Film-coated tablet

EU/1/11/731/002

2.5/850 milligram(s)

A10BD10

Film-coated tablet

EU/1/11/731/003

2.5/850 milligram(s)

A10BD10

Film-coated tablet

EU/1/11/731/004

2.5/850 milligram(s)

A10BD10

Film-coated tablet

EU/1/11/731/005

2.5/850 milligram(s)

A10BD10

Film-coated tablet

EU/1/11/731/006

2.5/850 milligram(s)

A10BD10

Film-coated tablet

Product Notice

Supply of Komboglyze 2.5mg-850mg Film-Coated Tablets to the Irish market will be discontinued by September 2024.